Opaleye Management Inc.'s Form 4 filing
Eton Pharmaceuticals, Inc. (ETON) · filed Jul 7, 2026
- Accession no.
- 0001493152-26-032394
- Filed
- Jul 7, 2026, 6:29 PM ET
- Trade date
- Jul 2-7, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $4.77M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −65,000 | $37.39F3 | −$2,430,031.5 | 2,710,000 | Indirect | |
| Jul 2, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −25,000 | $37.39F3 | −$934,627.5 | 60,000 | Indirect | |
| Jul 6, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −10,000 | $38.00 | −$380,000 | 2,700,000 | Indirect | |
| Jul 7, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −20,000 | $38.37F4 | −$767,456 | 2,680,000 | Indirect | |
| Jul 7, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −6,685 | $38.37F4 | −$256,522.17 | 53,315 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $37.85 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.565 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.